NCT03033784View on ClinicalTrials.gov

Autism Oxytocin Brain Project

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

October 3, 2018

Study Completion Date

October 3, 2018

Conditions
AutismAutism Spectrum Disorder
Interventions
DRUG

8 International Units (IU) of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 8IU.

DRUG

24IU of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 24IU.

DRUG

48IU of Oxytocin

Participants will receive one dose of intranasal oxytocin at a dose of 48IU.

DRUG

Placebo

Participants will receive an intranasal placebo to match the oxytocin doses.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER

NCT03033784 - Autism Oxytocin Brain Project | Biotech Hunter | Biotech Hunter